NCT04154488: An ongoing trial by X4 Pharmaceuticals
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 8 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04154488 |
|---|---|
| Title | A Phase 1b/2, Open-Label, Multicenter Study of Mavorixafor in Patients With Congenital Neutropenia and Chronic Neutropenia Disorders |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 16, 2021 |
| Completion date | Aug. 27, 2024 |
| Required reporting date | Aug. 27, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |